OTCMKTS:IOBCF Ion Beam Applications (IOBCF) Stock Price, News & Analysis → Just Released: Insider's Secret to Trading Options (From Schaeffer’s Research) (Ad) Free IOBCF Stock Alerts $13.90 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$13.90▼$13.9050-Day Range$10.35▼$15.0552-Week Range$8.65▼$18.00VolumeN/AAverage Volume383 shsMarket CapitalizationN/AP/E Ratio163.98Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Ion Beam Applications alerts: Email Address Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… About Ion Beam Applications Stock (OTCMKTS:IOBCF)Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.Read More IOBCF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IOBCF Stock News HeadlinesApril 17, 2024 | americanbankingnews.comIon Beam Applications SA (OTCMKTS:IOBCF) Short Interest UpdateApril 12, 2024 | msn.comASOIF withdraws IBA membership, calls for replacement boxing bodyApril 25, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 4, 2024 | reuters.comIBA says it may appeal after CAS upholds IOC decision to withdraw recognitionApril 4, 2024 | msn.comOlympics-IBA says it may appeal after CAS upholds IOC decision to withdraw recognitionApril 4, 2024 | msn.comBoost for boxing’s Olympic future as CAS reject IBA appeal against expulsion from IOCApril 4, 2024 | msn.comIBA to mull appeal in Swiss court against IOC recognition withdrawalApril 4, 2024 | msn.comIOC sets 'early 2025' deadline to keep boxing in Los Angeles OlympicsApril 25, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 2, 2024 | barrons.comCAS Rejects IBA Appeal To Organise Olympic BoxingApril 1, 2024 | msn.comIBA Karachi Students Boycott Coca-Cola Recruitment Drive Over Gaza ConflictMarch 21, 2024 | finanznachrichten.deIBA SA: IBA Reports Full Year 2023 ResultsMarch 21, 2024 | finance.yahoo.comIBA Reports Full Year 2023 ResultsMarch 19, 2024 | finance.yahoo.comIBA signs contract to install a Be-Efficient irradiation solution in GermanyMarch 15, 2024 | msn.comIBA hosts dialogue on menstrual hygiene and tax reformsMarch 11, 2024 | msn.comSalary Hike, Privilege Leave: Bank Employees Will Soon Enjoy 5 Benefits After IBA, Unions Sign PactFebruary 29, 2024 | finance.yahoo.comIBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West AfricaFebruary 29, 2024 | finance.yahoo.comIBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West AfricaFebruary 26, 2024 | finance.yahoo.comIBA Notice of Full Year 2023 Results and Conference CallFebruary 13, 2024 | finance.yahoo.comPanTera signs agreement with Bayer for the supply of actinium-225February 9, 2024 | finance.yahoo.comIBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presenceJanuary 30, 2024 | finance.yahoo.comIBA – TRANSPARENCY NOTIFICATIONJanuary 23, 2024 | finance.yahoo.comiThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70January 11, 2024 | msn.comFocused ion beam technology: A single tool for a wide range of applicationsDecember 21, 2023 | finance.yahoo.comIBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer CenterDecember 20, 2023 | finanznachrichten.deIBA SA: IBA celebrates a new milestone with the sale of the 100th Cyclone KIUBE cyclotronDecember 20, 2023 | finance.yahoo.comIBA celebrates a new milestone with the sale of the 100th Cyclone® KIUBE cyclotronSee More Headlines Receive IOBCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ion Beam Applications and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:IOBCF CUSIPN/A CIKN/A Webwww.iba-worldwide.com Phone(321) 047-5811FaxN/AEmployees2,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio163.98 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Pierre Mottet (Age 62)Chairman of The Board Comp: $56.87kMr. Olivier Legrain (Age 56)CEO, President, MD & Executive Director Comp: $953.2kMr. Yves Jongen (Age 77)Founder, Chief Research Officer, MD & Executive Director Comp: $624.91kMs. Soumya Chandramouli (Age 45)Chief Financial Officer Mr. Frederic Nolf (Age 51)Chief Human Resources & Sustainability Officer Marc Van der BurghtChief Operation OfficerOlivier LechienCorporate Communication DirectorThomas CanonSustainability Program DirectorBruno ScutnairePresident of IBA RadioPharma SolutionsMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors IOBCF Stock Analysis - Frequently Asked Questions How have IOBCF shares performed in 2024? Ion Beam Applications' stock was trading at $12.46 at the beginning of 2024. Since then, IOBCF shares have increased by 11.6% and is now trading at $13.90. View the best growth stocks for 2024 here. Are investors shorting Ion Beam Applications? Ion Beam Applications saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 16,300 shares, a drop of 7.9% from the March 15th total of 17,700 shares. Based on an average daily trading volume, of 200 shares, the short-interest ratio is currently 81.5 days. View Ion Beam Applications' Short Interest. How do I buy shares of Ion Beam Applications? Shares of IOBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IOBCF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupWill this $2 AI stock double overnight?Behind the MarketsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ion Beam Applications SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.